Evidence against dopaminergic and further support for alpha-adrenergic receptor involvement in the pineal phosphatidylinositol effect.
D000818:Animals; D001667:Binding, Competitive; D004298:Dopamine / Q000378:metabolism / Q000494:pharmacology; D007700:Kinetics; D009638:Norepinephrine / Q000378:metabolism / Q000494:pharmacology; D010716:Phosphatidylinositols / Q000096:biosynthesis*; D010743:Phospholipids / Q000096:biosynthesis; D010870:Pineal Gland / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D011941:Receptors, Adrenergic / Q000502:physiology*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects / Q000502:physiology*; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology*
D010716:Phosphatidylinositols; D010743:Phospholipids; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D011954:Receptors, Dopamine; D004298:Dopamine; D009638:Norepinephrine